Background In most countries, contacts of confirmed COVID-19 cases are asked to quarantine
for 14 days after exposure to limit asymptomatic onward transmission. While theoretically …

Background The COVID-19 pandemic has resulted in unprecedented disruption to society,
which indirectly affects infectious disease dynamics. We aimed to assess the effects of COVID…

Background In response to the COVID-19 pandemic, the UK first adopted physical distancing
measures in March, 2020. Vaccines against SARS-CoV-2 became available in December, …

Background We aimed to quantify the unknown losses in health-related quality of life of
coronavirus disease 2019 (COVID-19) cases using quality-adjusted lifedays (QALDs) and the …

Background Countries in the World Health Organization (WHO) European Region differ in
terms of the COVID-19 vaccine supply conditions. We evaluated the health and economic …

Background In settings where the COVID-19 vaccine supply is constrained, extending the
intervals between the first and second doses of the COVID-19 vaccine may allow more people …

Opportunity costs of bed‐days are fundamental to understanding the value of healthcare
systems. They greatly influence burden of disease estimations and economic evaluations …

In The Lancet Infectious Diseases, Eric Haas and colleagues1 estimated the benefits of the
rapid mass roll-out of the Pfizer–BioNTech vaccine in Israel between Dec 20, 2020, and April …

Background Norovirus places a substantial burden on healthcare systems, arising from
infected patients, disease outbreaks, beds kept unoccupied for infection control, and staff …

Introduction Despite seasonal influenza vaccination programmes in most countries targeting
individuals aged ≥ 65 (or ≥ 55) years and high risk-groups, significant disease burden …